Skip to Content

Apidra

In the US, Apidra (insulin glulisine systemic) is a member of the drug class insulin and is used to treat Diabetes - Type 1, Diabetes - Type 2, Diabetic Ketoacidosis and Nonketotic Hyperosmolar Syndrome.

US matches:

UK matches:

Ingredient matches for Apidra

Insulin Glargine

Insulin Glargine is reported as an ingredient of Apidra in the following countries:

  • China

Insulin Glulisine

Insulin Glulisine is reported as an ingredient of Apidra in the following countries:

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Bosnia & Herzegowina
  • Chile
  • Colombia
  • Costa Rica
  • Cyprus
  • Denmark
  • Dominican Republic
  • Ecuador
  • Egypt
  • El Salvador
  • Finland
  • France
  • Georgia
  • Germany
  • Guatemala
  • Honduras
  • Hong Kong
  • Hungary
  • Iceland
  • Indonesia
  • Ireland
  • Italy
  • Japan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • New Zealand
  • Nicaragua
  • Norway
  • Oman
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Russian Federation
  • Serbia
  • Singapore
  • Slovakia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • Tunisia
  • Turkey
  • United Kingdom

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide